Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”

H. Bulluck; J. Nicholas; G. Crimi; S.K. White; A.J. Ludman; S. Pica; C. Raineri; H.A. Cabrera-Fuentes; D.M. Yellon; J. Rodriguez-Palomares; D. Garcia-Dorado; D.J. Hausenloy

doi:10.1016/j.ijcard.2017.02.112

Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”

H. Bulluck, J. Nicholas, G. Crimi, S.K. White, A.J. Ludman, S. Pica, C. Raineri, H.A. Cabrera-Fuentes, D.M. Yellon, J. Rodriguez-Palomares, D. Garcia-Dorado, D.J. Hausenloy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	192-193
Number of pages	2
Journal	International Journal of Cardiology
Volume	235
DOIs	https://doi.org/10.1016/j.ijcard.2017.02.112
Publication status	Published - 2017

Keywords

melatonin
acute heart infarction
blood clot lysis
blood vessel occlusion
circadian rhythm
heart infarction size
heart protection
human
Letter
myocardial ischemia reperfusion injury
percutaneous coronary intervention
protein expression
ST segment elevation myocardial infarction
suprachiasmatic nucleus
heart infarction
Circadian Rhythm
Humans
Melatonin
Myocardial Infarction
Suprachiasmatic Nucleus

Access to Document

10.1016/j.ijcard.2017.02.112

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015921771&doi=10.1016%2fj.ijcard.2017.02.112&partnerID=40&md5=359d2776fa1f33bb0adc8d0a50e6fa04

Cite this

Bulluck, H., Nicholas, J., Crimi, G., White, S. K., Ludman, A. J., Pica, S., Raineri, C., Cabrera-Fuentes, H. A., Yellon, D. M., Rodriguez-Palomares, J., Garcia-Dorado, D., & Hausenloy, D. J. (2017). Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”. International Journal of Cardiology, 235, 192-193. https://doi.org/10.1016/j.ijcard.2017.02.112

Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”. / Bulluck, H.; Nicholas, J.; Crimi, G.; White, S.K.; Ludman, A.J.; Pica, S.; Raineri, C.; Cabrera-Fuentes, H.A.; Yellon, D.M.; Rodriguez-Palomares, J.; Garcia-Dorado, D.; Hausenloy, D.J.

In: International Journal of Cardiology, Vol. 235, 2017, p. 192-193.

Research output: Contribution to journal › Article › peer-review

Bulluck, H, Nicholas, J, Crimi, G, White, SK, Ludman, AJ, Pica, S , Raineri, C, Cabrera-Fuentes, HA, Yellon, DM, Rodriguez-Palomares, J, Garcia-Dorado, D & Hausenloy, DJ 2017, 'Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”', International Journal of Cardiology, vol. 235, pp. 192-193. https://doi.org/10.1016/j.ijcard.2017.02.112

Bulluck, H. ; Nicholas, J. ; Crimi, G. ; White, S.K. ; Ludman, A.J. ; Pica, S. ; Raineri, C. ; Cabrera-Fuentes, H.A. ; Yellon, D.M. ; Rodriguez-Palomares, J. ; Garcia-Dorado, D. ; Hausenloy, D.J. / Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”. In: International Journal of Cardiology. 2017 ; Vol. 235. pp. 192-193.

@article{9b5de7146932418ba1fd647ace148be4,

title = "Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”",

keywords = "melatonin, acute heart infarction, blood clot lysis, blood vessel occlusion, circadian rhythm, heart infarction size, heart protection, human, Letter, myocardial ischemia reperfusion injury, percutaneous coronary intervention, protein expression, ST segment elevation myocardial infarction, suprachiasmatic nucleus, heart infarction, Circadian Rhythm, Humans, Melatonin, Myocardial Infarction, Suprachiasmatic Nucleus",

author = "H. Bulluck and J. Nicholas and G. Crimi and S.K. White and A.J. Ludman and S. Pica and C. Raineri and H.A. Cabrera-Fuentes and D.M. Yellon and J. Rodriguez-Palomares and D. Garcia-Dorado and D.J. Hausenloy",

note = "Export Date: 2 March 2018 CODEN: IJCDD Correspondence Address: Hausenloy, D.J.; Cardiovascular & Metabolic Diseases Program, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore; email: derek.hausenloy@duke-nus.edu.sg Chemicals/CAS: melatonin, 73-31-4; Melatonin Funding details: DFG, California Department of Fish and Game Funding details: FS/10/039/28270, BHF, British Heart Foundation Funding details: Rosetrees Trust Funding details: DFG, Deutsche Forschungsgemeinschaft Funding text: Part of this work was supported by the British Heart Foundation (FS/10/039/28270), the Rosetrees Trust, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. HACF is funded by a Startup Grant of the ?Excellence Cluster Cardio-Pulmonary System? (ECCPS) from the German Research Foundation (DFG, Bonn, Germany) and the ?Peter und Traudl Engelhorn-Stiftung? (Weilheim, Germany). References: Bulluck, H., Nicholas, J., Crimi, G., White, S.K., Ludman, A.J., Pica, S., Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients (2017) Int. J. Cardiol., 230, pp. 149-154; Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J.M., Gonzalez-Gonzalez, J., Garcia-Camarero, T., Consuegra-Sanchez, L., Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial (2017) J. Pineal Res.; Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Reiter, R.J., Melatonin as an agent for cardioprotection in patients with ST-elevation myocardial infarction and short ischaemic time (2017) Cardiovasc. Drugs Ther.; Bulluck, H., Yellon, D.M., Hausenloy, D.J., Reducing myocardial infarct size: challenges and future opportunities (2016) Heart, 102, pp. 341-348; Bulluck, H., Hausenloy, D.J., Microvascular obstruction: the bane of myocardial reperfusion (2015) Rev. Esp. Cardiol., 68, pp. 919-920; Bulluck, H., Foin, N., Tan, J.W., Low, A.F., Sezer, M., Hausenloy, D.J., Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand? (2017) Circ. Cardiovasc. Interv., 10",

year = "2017",

doi = "10.1016/j.ijcard.2017.02.112",

language = "English",

volume = "235",

pages = "192--193",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Reply to “Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei”

AU - Bulluck, H.

AU - Nicholas, J.

AU - Crimi, G.

AU - White, S.K.

AU - Ludman, A.J.

AU - Pica, S.

AU - Raineri, C.

AU - Cabrera-Fuentes, H.A.

AU - Yellon, D.M.

AU - Rodriguez-Palomares, J.

AU - Garcia-Dorado, D.

AU - Hausenloy, D.J.

N1 - Export Date: 2 March 2018 CODEN: IJCDD Correspondence Address: Hausenloy, D.J.; Cardiovascular & Metabolic Diseases Program, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore; email: derek.hausenloy@duke-nus.edu.sg Chemicals/CAS: melatonin, 73-31-4; Melatonin Funding details: DFG, California Department of Fish and Game Funding details: FS/10/039/28270, BHF, British Heart Foundation Funding details: Rosetrees Trust Funding details: DFG, Deutsche Forschungsgemeinschaft Funding text: Part of this work was supported by the British Heart Foundation (FS/10/039/28270), the Rosetrees Trust, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. HACF is funded by a Startup Grant of the ?Excellence Cluster Cardio-Pulmonary System? (ECCPS) from the German Research Foundation (DFG, Bonn, Germany) and the ?Peter und Traudl Engelhorn-Stiftung? (Weilheim, Germany). References: Bulluck, H., Nicholas, J., Crimi, G., White, S.K., Ludman, A.J., Pica, S., Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients (2017) Int. J. Cardiol., 230, pp. 149-154; Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J.M., Gonzalez-Gonzalez, J., Garcia-Camarero, T., Consuegra-Sanchez, L., Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial (2017) J. Pineal Res.; Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Reiter, R.J., Melatonin as an agent for cardioprotection in patients with ST-elevation myocardial infarction and short ischaemic time (2017) Cardiovasc. Drugs Ther.; Bulluck, H., Yellon, D.M., Hausenloy, D.J., Reducing myocardial infarct size: challenges and future opportunities (2016) Heart, 102, pp. 341-348; Bulluck, H., Hausenloy, D.J., Microvascular obstruction: the bane of myocardial reperfusion (2015) Rev. Esp. Cardiol., 68, pp. 919-920; Bulluck, H., Foin, N., Tan, J.W., Low, A.F., Sezer, M., Hausenloy, D.J., Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand? (2017) Circ. Cardiovasc. Interv., 10

PY - 2017

Y1 - 2017

KW - melatonin

KW - acute heart infarction

KW - blood clot lysis

KW - blood vessel occlusion

KW - circadian rhythm

KW - heart infarction size

KW - heart protection

KW - human

KW - Letter

KW - myocardial ischemia reperfusion injury

KW - percutaneous coronary intervention

KW - protein expression

KW - ST segment elevation myocardial infarction

KW - suprachiasmatic nucleus

KW - heart infarction

KW - Circadian Rhythm

KW - Humans

KW - Melatonin

KW - Myocardial Infarction

KW - Suprachiasmatic Nucleus

U2 - 10.1016/j.ijcard.2017.02.112

DO - 10.1016/j.ijcard.2017.02.112

M3 - Article

VL - 235

SP - 192

EP - 193

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -